MRK vs IQV
By Alex · Tickerpine
Merck & Company, Inc. vs IQVIA Holdings Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | IQV |
|---|---|---|
| Price | $132.92 | $241.71 |
| Market cap | $327.94B | $39.79B |
| P/E ratio | 106.3 | 30.0 |
| ROE | 6.96% | 22.82% |
| Profit margin | 4.77% | 8.10% |
| Revenue growth | 5.10% | 8.70% |
| Dividend yield | 2.56% | — |
| Beta | 0.21 | 1.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs IQV in plain English
- MRK is the bigger company — about 8.2× the market cap of IQV.
- IQV is cheaper on earnings (P/E 30.0 vs 106.3).
- IQV earns a higher return on equity (23% vs 7%).
- IQV is growing revenue faster (9% vs 5%).
- MRK pays a dividend (2.56%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
IQV return calculator
See what $1,000 in IQVIA Holdings Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.